Drug Shortage Report for PMS-EVEROLIMUS

Last updated on 2025-01-27 History
Report ID 246213
Drug Identification Number 02504677
Brand name PMS-EVEROLIMUS
Common or Proper name EVEROLIMUS
Company Name PHARMASCIENCE INC
Market Status MARKETED
Active Ingredient(s) EVEROLIMUS
Strength(s) 2.5MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 30
ATC code L04AH
ATC description
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-12-19
Estimated end date 2025-01-24
Actual end date 2025-01-26
Shortage status Resolved
Updated date 2025-01-27
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 6111 ROYALMOUNT AVE
MONTREAL, QUEBEC
CANADA H4P 2T4
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2025-01-27 French Compare
v7 2025-01-27 English Compare
v6 2025-01-17 French Compare
v5 2025-01-17 English Compare
v4 2025-01-07 French Compare
v3 2025-01-07 English Compare
v2 2024-12-20 French Compare
v1 2024-12-20 English Compare

Showing 1 to 8 of 8